Signaturefd, LLC Argenx Se Transaction History

Signaturefd, LLC

$5.4 Billion
Q2 2025

A detailed history of Signaturefd, LLC transactions in Argenx Se stock. As of the latest transaction made, Signaturefd, LLC holds 1,679 shares of ARGX stock, worth $1.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,679

Previous 1,687 0.47%

Holding current value

$1.34 Million

Previous $998,000 7.31%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	SELL	$532.27 - $656.65 $4,258 - $5,253	-8 Reduced 0.47%	1,679 $925,000
Q1 2025 May 01, 2025	SELL	$571.0 - $671.75 $66,807 - $78,594	-117 Reduced 6.49%	1,687 $998,000
Q4 2024 Feb 10, 2025	BUY	$520.52 - $638.33 $86,926 - $106,601	167 Added 10.2%	1,804 $1.11 Million
Q3 2024 Oct 21, 2024	BUY	$434.22 - $551.9 $105,081 - $133,559	242 Added 17.35%	1,637 $887,000
Q2 2024 Jul 29, 2024	SELL	$356.01 - $451.55 $17,088 - $21,674	-48 Reduced 3.33%	1,395 $599,000
Q1 2024 May 03, 2024	BUY	$356.95 - $413.29 $27,842 - $32,236	78 Added 5.71%	1,443 $568,000
Q4 2023 Jan 31, 2024	SELL	$338.91 - $506.01 $15,250 - $22,770	-45 Reduced 3.19%	1,365 $519,000
Q3 2023 Nov 03, 2023	BUY	$369.35 - $548.43 $103,418 - $153,560	280 Added 24.78%	1,410 $693,000
Q2 2023 Aug 01, 2023	BUY	$360.14 - $422.58 $33,493 - $39,299	93 Added 8.97%	1,130 $440,000
Q1 2023 Apr 28, 2023	SELL	$334.23 - $403.65 $17,045 - $20,586	-51 Reduced 4.69%	1,037 $386,000
Q4 2022 Jan 27, 2023	SELL	$342.17 - $402.31 $72,540 - $85,289	-212 Reduced 16.31%	1,088 $412,000
Q3 2022 Nov 08, 2022	BUY	$343.2 - $395.75 $103,646 - $119,516	302 Added 30.26%	1,300 $459,000
Q2 2022 Aug 10, 2022	BUY	$269.58 - $378.88 $126,433 - $177,694	469 Added 88.66%	998 $378,000
Q1 2022 May 02, 2022	SELL	$254.45 - $351.06 $32,060 - $44,233	-126 Reduced 19.24%	529 $167,000
Q4 2021 Jan 25, 2022	BUY	$272.01 - $353.03 $30,465 - $39,539	112 Added 20.63%	655 $229,000
Q3 2021 Oct 28, 2021	BUY	$295.0 - $350.58 $45,430 - $53,989	154 Added 39.59%	543 $164,000
Q2 2021 Jul 26, 2021	BUY	$257.11 - $319.92 $8,484 - $10,557	33 Added 9.27%	389 $117,000
Q1 2021 Apr 30, 2021	BUY	$268.3 - $380.31 $38,098 - $54,004	142 Added 66.36%	356 $98,000
Q4 2020 Feb 11, 2021	BUY	$248.13 - $308.36 $37,467 - $46,562	151 Added 239.68%	214 $63,000
Q3 2020 Nov 03, 2020	BUY	$215.51 - $272.51 $11,637 - $14,715	54 Added 600.0%	63 $17,000
Q2 2020 Jul 30, 2020	BUY	$127.44 - $232.72 $509 - $930	4 Added 80.0%	9 $2,000
Q1 2020 Apr 23, 2020	BUY	$108.83 - $165.23 $544 - $826	5 New	5 $1,000

Others Institutions Holding ARGX

# of Institutions

492

Shares Held

28.1M

Call Options Held

370K

Put Options Held

211K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $44.1B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account